Publication: Disease model: LAMP-2 enlightens Danon disease
| dc.bibliographiccitation.firstpage | 37 | |
| dc.bibliographiccitation.issue | 1 | |
| dc.bibliographiccitation.journal | Trends in Molecular Medicine | |
| dc.bibliographiccitation.lastpage | 39 | |
| dc.bibliographiccitation.volume | 7 | |
| dc.contributor.author | Saftig, P. | |
| dc.contributor.author | Tanaka, Y. | |
| dc.contributor.author | Lullmann-Rauch, R. | |
| dc.contributor.author | von Figura, Kurt | |
| dc.date.accessioned | 2018-11-07T09:40:13Z | |
| dc.date.available | 2018-11-07T09:40:13Z | |
| dc.date.issued | 2001 | |
| dc.description.abstract | Danon disease ('lysosomal glycogen storage disease with normal acid maltase') is characterized by a cardiomyopathy, myopathy and variable mental retardation. Mutations in the coding sequence of the lysosomal-associated membrane protein 2 (LAMP-2) were shown to cause a LAMP-2 deficiency in patients with Danon disease. LAMP-2 deficient mice manifest a similar vacuolar cardioskeletal myopathy. In addition to the patient reports LAMP-2 deficiency in mice causes pancreatic, hepatocytic, endothelial and leucocyte vacuolation. LAMP-2 deficient mice represent a valuable animal model of Danon disease. They will further be used to study the exact role of LAMP-P in autophagy and to analyse the consequences of an impaired autophagic pathway in various tissues. | |
| dc.identifier.doi | 10.1016/S1471-4914(00)01868-2 | |
| dc.identifier.isi | 000169932200010 | |
| dc.identifier.pmid | 11427988 | |
| dc.identifier.uri | https://resolver.sub.uni-goettingen.de/purl?gro-2/33461 | |
| dc.notes.status | zu prüfen | |
| dc.notes.submitter | Najko | |
| dc.publisher | Elsevier Sci Ltd | |
| dc.relation.issn | 1471-4914 | |
| dc.title | Disease model: LAMP-2 enlightens Danon disease | |
| dc.type | review | |
| dc.type.internalPublication | yes | |
| dc.type.peerReviewed | yes | |
| dc.type.status | published | |
| dspace.entity.type | Publication |